Nina Skorytchenko MA

Nina is the founder and CEO of Avenna and Wellcode Life. She is working in close collaboration with leading scientists and professionals in the field of precision health & wellness. At her company Avenna, she is specializing in the translation of precision medicine tools into clinical practice for Inflammatory conditions.

Nina started her career in the City of London and worked at large corporations such as Schlumberger, Bloomberg, and Nomura as well as multifamily offices. In the last five years, her focus was on preventative healthcare and translational medicine. At her scientific wellness company Wellcode, she delivers personalized preventive health transformation programs for corporate and individual clients.